Terms: = Lung cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Prognosis
15 results:
1. Structure-Based Discovery and Biological Assays of a Novel PRMT5 Inhibitor for Non-Small Cell lung cancer.
Chen Y; Zhang M; Wu A; Yao X; Wang Q
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364261
[TBL] [Abstract] [Full Text] [Related]
2. Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment.
Li J; Hu K; Huang J; Zhou L; Yan Y; Xu Z
Aging (Albany NY); 2021 Jun; 13(12):16541-16566. PubMed ID: 34160364
[TBL] [Abstract] [Full Text] [Related]
3. Epidemiology and prognosis in young lung cancer patients aged under 45 years old in northern China.
Shi J; Li D; Liang D; He Y
Sci Rep; 2021 Mar; 11(1):6817. PubMed ID: 33767239
[TBL] [Abstract] [Full Text] [Related]
4. miR-24-3p/fgfr3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates lung Adenocarcinoma Progression.
Jing P; Zhao N; Xie N; Ye M; Zhang Y; Zhang Z; Li M; Lai X; Zhang J; Gu Z
J Immunol Res; 2018; 2018():2834109. PubMed ID: 29850625
[TBL] [Abstract] [Full Text] [Related]
5. [Preliminary study of exon sequence in pneumoconiosis and pneumoconiosis complicated with lung cancer using high-throughput sequencing technology].
Jiang MF; Li L; Wang Z; Zhang CL; Zhang H
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 Nov; 35(11):801-806. PubMed ID: 29316748
[No Abstract] [Full Text] [Related]
6. FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.
Flockerzi FA; Roggia C; Langer F; Holleczek B; Bohle RM
Virchows Arch; 2018 May; 472(5):759-769. PubMed ID: 29270870
[TBL] [Abstract] [Full Text] [Related]
7. Mutational Diversity of lung cancer and Associated Lymph Nodes. An Exploratory Prospective Study of 4 Resected cIIIA-N2.
Legras A; Roussel H; Mangiameli G; Arame A; Grand B; Pricopi C; Badia A; Gibault L; Badoual C; Fabre E; Laurent-Puig P; Blons H; Le Pimpec-Barthes F
Pathol Oncol Res; 2019 Jan; 25(1):319-325. PubMed ID: 29110262
[TBL] [Abstract] [Full Text] [Related]
8. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
[TBL] [Abstract] [Full Text] [Related]
9. Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer.
Garelli E; Renaud S; Falcoz PE; Weingertner N; Olland A; Santelmo N; Massard G
Eur J Cardiothorac Surg; 2016 Aug; 50(2):322-8. PubMed ID: 26920941
[TBL] [Abstract] [Full Text] [Related]
10. IM-412 inhibits the invasion of human breast carcinoma cells by blocking FGFR-mediated signaling.
Jung SY; Yi JY; Kim MH; Song KH; Kang SM; Ahn J; Hwang SG; Nam KY; Song JY
Oncol Rep; 2015 Nov; 34(5):2731-7. PubMed ID: 26351897
[TBL] [Abstract] [Full Text] [Related]
11. Genomic analysis of metastatic cutaneous squamous cell carcinoma.
Li YY; Hanna GJ; Laga AC; Haddad RI; Lorch JH; Hammerman PS
Clin Cancer Res; 2015 Mar; 21(6):1447-56. PubMed ID: 25589618
[TBL] [Abstract] [Full Text] [Related]
12. Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.
Wen YS; Cai L; Zhang XW; Zhu JF; Zhang ZC; Shao JY; Zhang LJ
Medicine (Baltimore); 2014 Dec; 93(29):e296. PubMed ID: 25546673
[TBL] [Abstract] [Full Text] [Related]
13. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.
Yoon SO; Kim YT; Jung KC; Jeon YK; Kim BH; Kim CW
Lung Cancer; 2011 Feb; 71(2):209-16. PubMed ID: 20471712
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
[TBL] [Abstract] [Full Text] [Related]
15. Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer.
Groen HJ; Smit EF; Haaxma-Reiche H; Postmus PE
Eur J Cancer; 1993; 29A(12):1696-9. PubMed ID: 7691116
[TBL] [Abstract] [Full Text] [Related]
